Takeda Pharmaceutical
TAK
#362
Rank
HK$526.60 B
Marketcap
HK$164.83
Share price
-0.80%
Change (1 day)
54.60%
Change (1 year)

EPS for Takeda Pharmaceutical (TAK)

EPS in 2023 (TTM): HK$3.63

According to Takeda Pharmaceutical's latest financial reports the company's current EPS (TTM) is HK$4.57. In 2022 the company made an earnings per share (EPS) of HK$5.10 a decrease over its 2021 EPS that were of HK$9.89.

EPS history for Takeda Pharmaceutical from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$3.63-28.87%
2022HK$5.10-48.38%
2021HK$9.89129.33%
2020HK$4.311194.61%
2019HK$0.33-93.1%
2018HK$4.83-43.22%
2017HK$8.5033.37%
2016HK$6.37-236.78%
2015-HK$4.66-294.41%
2014HK$2.40-66.04%
2013HK$7.069.95%
2012HK$6.42-46.86%
2011HK$12.08-18.07%
2010HK$14.75-13.68%
2009HK$17.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.42 1,047.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.17 801.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96 30.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$127.19 2,684.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$14.92 226.72%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$7.78 70.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.56 394.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-HK$31.44-788.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$2.84-37.83%๐Ÿ‡ฎ๐Ÿ‡ณ India